Sylvain Pilorge

Villejuif, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Therapy related myeloid neoplasm, same but different?

Therapy related myeloid neoplasm, same but different?

Journal: Bulletin du cancer

Published: May 13, 2025

Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Journal: The Lancet. Haematology

Published: July 28, 2023

Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantation.

Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantation.

Journal: Immunotherapy

Published: March 23, 2023

Intercontinental Multidisciplinary Oncology Videoconferencing for Rare and Complex Cancer: An Alternative to Systematic Transfer.

Intercontinental Multidisciplinary Oncology Videoconferencing for Rare and Complex Cancer: An Alternative to Systematic Transfer.

Journal: JCO oncology practice

Published: February 23, 2021

Donor Lymphocyte Infusions After Allogeneic Transplantation: A Single-Center Experience.

Donor Lymphocyte Infusions After Allogeneic Transplantation: A Single-Center Experience.

Journal: Clinical lymphoma, myeloma & leukemia

Published: August 12, 2019

More on Blastic Plasmacytoid Dendritic-Cell Neoplasms.

More on Blastic Plasmacytoid Dendritic-Cell Neoplasms.

Journal: The New England journal of medicine

Published: February 21, 2019

Efficacy and safety of high-dose etoposide cytarabine as consolidation following rituximab methotrexate temozolomide induction in newly diagnosed primary central nervous system lymphoma in immunocompetent patients.

Efficacy and safety of high-dose etoposide cytarabine as consolidation following rituximab methotrexate temozolomide induction in newly diagnosed primary central nervous system lymphoma in immunocompetent patients.

Journal: Haematologica

Published: February 24, 2018

Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patients.

Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patients.

Journal: Oncotarget

Published: December 17, 2017

A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experience.

A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experience.

Journal: Leukemia & lymphoma

Published: November 23, 2017

Hodgkin lymphoma: Current and future therapeutic strategies

Hodgkin lymphoma: Current and future therapeutic strategies

Journal: Bulletin du cancer

Published: July 14, 2017

Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation-a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.

Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation-a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.

Journal: Bone marrow transplantation

Published: July 04, 2017

Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents.

Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents.

Journal: Blood cancer journal

Published: May 13, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026